Loading…
Epidermal powder immunization of mice and monkeys with an influenza vaccine
Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the i...
Saved in:
Published in: | Vaccine 2003-06, Vol.21 (21), p.2830-2836 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953 |
---|---|
cites | cdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953 |
container_end_page | 2836 |
container_issue | 21 |
container_start_page | 2830 |
container_title | Vaccine |
container_volume | 21 |
creator | Chen, Dexiang Endres, Ryan Maa, Yuh-Fun Kensil, Charlotte R. Whitaker-Dowling, Patricia Trichel, Anita Youngner, Julius S. Payne, Lendon G. |
description | Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine. |
doi_str_mv | 10.1016/S0264-410X(03)00175-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18780160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X03001750</els_id><sourcerecordid>18780160</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</originalsourceid><addsrcrecordid>eNqFkNFqFTEQhoNY7LH6CEpAFL1YnWSz2eyVSKlaWvBCBe9CTjLB1N3kNNltaZ_enJ6DBW96NcPw_T_DR8gLBu8ZMPnhO3ApGsHg11to3wGwvmvgEVkx1bcN75h6TFb_kEPytJQLAOhaNjwhh4z3g5JcrMjZySY4zJMZ6SZd142GaVpiuDVzSJEmT6dgkZro6JTiH7wp9DrMv-uBhujHBeOtoVfG2hDxGTnwZiz4fD-PyM_PJz-Ovzbn376cHn86b6zoYG7W_Rr9ugXVD2iF4ODsIIy3vjWMGy-Aqw6tlOC9QHBOciWZV171Dmuma4_Im13vJqfLBcusp1AsjqOJmJaiqwJVFUEFX_0HXqQlx_qbZmKQUqhBsUp1O8rmVEpGrzc5TCbfaAZ661rfudZbkRpafedab9tf7tuX9YTuPrWXW4HXe8AUa0afTbSh3HNCyW6QvHIfdxxWaVcBsy42YLToQkY7a5fCA6_8BdNNmzY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1496648981</pqid></control><display><type>article</type><title>Epidermal powder immunization of mice and monkeys with an influenza vaccine</title><source>Elsevier</source><creator>Chen, Dexiang ; Endres, Ryan ; Maa, Yuh-Fun ; Kensil, Charlotte R. ; Whitaker-Dowling, Patricia ; Trichel, Anita ; Youngner, Julius S. ; Payne, Lendon G.</creator><creatorcontrib>Chen, Dexiang ; Endres, Ryan ; Maa, Yuh-Fun ; Kensil, Charlotte R. ; Whitaker-Dowling, Patricia ; Trichel, Anita ; Youngner, Julius S. ; Payne, Lendon G.</creatorcontrib><description>Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(03)00175-0</identifier><identifier>PMID: 12798624</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adjuvant ; Adjuvants, Immunologic - administration & dosage ; Administration, Cutaneous ; Animals ; Antibodies, Viral - blood ; Biological and medical sciences ; Cholera ; Cholera Toxin - immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Fundamental and applied biological sciences. Psychology ; Hemagglutination Inhibition Tests ; Immune system ; Immunity, Mucosal ; Immunization ; Immunogenicity ; Influenza ; Influenza Vaccines - administration & dosage ; Influenza Vaccines - immunology ; Injection ; Injections, Intramuscular ; Macaca mulatta ; Methods ; Mice ; Mice, Inbred BALB C ; Microbiology ; Monkeys & apes ; Mortality ; Mucosal antibody ; Orthomyxoviridae Infections - immunology ; Orthomyxoviridae Infections - prevention & control ; Powders ; Primate ; Rodents ; Saponins - administration & dosage ; Saponins - immunology ; Species Specificity ; Toxins ; Vaccination - methods ; Vaccine ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies ; Virology ; Viruses ; Waterborne diseases</subject><ispartof>Vaccine, 2003-06, Vol.21 (21), p.2830-2836</ispartof><rights>2003 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jun 20, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</citedby><cites>FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14865962$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12798624$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Dexiang</creatorcontrib><creatorcontrib>Endres, Ryan</creatorcontrib><creatorcontrib>Maa, Yuh-Fun</creatorcontrib><creatorcontrib>Kensil, Charlotte R.</creatorcontrib><creatorcontrib>Whitaker-Dowling, Patricia</creatorcontrib><creatorcontrib>Trichel, Anita</creatorcontrib><creatorcontrib>Youngner, Julius S.</creatorcontrib><creatorcontrib>Payne, Lendon G.</creatorcontrib><title>Epidermal powder immunization of mice and monkeys with an influenza vaccine</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.</description><subject>Adjuvant</subject><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Administration, Cutaneous</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>Cholera</subject><subject>Cholera Toxin - immunology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hemagglutination Inhibition Tests</subject><subject>Immune system</subject><subject>Immunity, Mucosal</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Influenza</subject><subject>Influenza Vaccines - administration & dosage</subject><subject>Influenza Vaccines - immunology</subject><subject>Injection</subject><subject>Injections, Intramuscular</subject><subject>Macaca mulatta</subject><subject>Methods</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Microbiology</subject><subject>Monkeys & apes</subject><subject>Mortality</subject><subject>Mucosal antibody</subject><subject>Orthomyxoviridae Infections - immunology</subject><subject>Orthomyxoviridae Infections - prevention & control</subject><subject>Powders</subject><subject>Primate</subject><subject>Rodents</subject><subject>Saponins - administration & dosage</subject><subject>Saponins - immunology</subject><subject>Species Specificity</subject><subject>Toxins</subject><subject>Vaccination - methods</subject><subject>Vaccine</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</subject><subject>Virology</subject><subject>Viruses</subject><subject>Waterborne diseases</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkNFqFTEQhoNY7LH6CEpAFL1YnWSz2eyVSKlaWvBCBe9CTjLB1N3kNNltaZ_enJ6DBW96NcPw_T_DR8gLBu8ZMPnhO3ApGsHg11to3wGwvmvgEVkx1bcN75h6TFb_kEPytJQLAOhaNjwhh4z3g5JcrMjZySY4zJMZ6SZd142GaVpiuDVzSJEmT6dgkZro6JTiH7wp9DrMv-uBhujHBeOtoVfG2hDxGTnwZiz4fD-PyM_PJz-Ovzbn376cHn86b6zoYG7W_Rr9ugXVD2iF4ODsIIy3vjWMGy-Aqw6tlOC9QHBOciWZV171Dmuma4_Im13vJqfLBcusp1AsjqOJmJaiqwJVFUEFX_0HXqQlx_qbZmKQUqhBsUp1O8rmVEpGrzc5TCbfaAZ661rfudZbkRpafedab9tf7tuX9YTuPrWXW4HXe8AUa0afTbSh3HNCyW6QvHIfdxxWaVcBsy42YLToQkY7a5fCA6_8BdNNmzY</recordid><startdate>20030620</startdate><enddate>20030620</enddate><creator>Chen, Dexiang</creator><creator>Endres, Ryan</creator><creator>Maa, Yuh-Fun</creator><creator>Kensil, Charlotte R.</creator><creator>Whitaker-Dowling, Patricia</creator><creator>Trichel, Anita</creator><creator>Youngner, Julius S.</creator><creator>Payne, Lendon G.</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20030620</creationdate><title>Epidermal powder immunization of mice and monkeys with an influenza vaccine</title><author>Chen, Dexiang ; Endres, Ryan ; Maa, Yuh-Fun ; Kensil, Charlotte R. ; Whitaker-Dowling, Patricia ; Trichel, Anita ; Youngner, Julius S. ; Payne, Lendon G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adjuvant</topic><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Administration, Cutaneous</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>Cholera</topic><topic>Cholera Toxin - immunology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hemagglutination Inhibition Tests</topic><topic>Immune system</topic><topic>Immunity, Mucosal</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Influenza</topic><topic>Influenza Vaccines - administration & dosage</topic><topic>Influenza Vaccines - immunology</topic><topic>Injection</topic><topic>Injections, Intramuscular</topic><topic>Macaca mulatta</topic><topic>Methods</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Microbiology</topic><topic>Monkeys & apes</topic><topic>Mortality</topic><topic>Mucosal antibody</topic><topic>Orthomyxoviridae Infections - immunology</topic><topic>Orthomyxoviridae Infections - prevention & control</topic><topic>Powders</topic><topic>Primate</topic><topic>Rodents</topic><topic>Saponins - administration & dosage</topic><topic>Saponins - immunology</topic><topic>Species Specificity</topic><topic>Toxins</topic><topic>Vaccination - methods</topic><topic>Vaccine</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</topic><topic>Virology</topic><topic>Viruses</topic><topic>Waterborne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Dexiang</creatorcontrib><creatorcontrib>Endres, Ryan</creatorcontrib><creatorcontrib>Maa, Yuh-Fun</creatorcontrib><creatorcontrib>Kensil, Charlotte R.</creatorcontrib><creatorcontrib>Whitaker-Dowling, Patricia</creatorcontrib><creatorcontrib>Trichel, Anita</creatorcontrib><creatorcontrib>Youngner, Julius S.</creatorcontrib><creatorcontrib>Payne, Lendon G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Dexiang</au><au>Endres, Ryan</au><au>Maa, Yuh-Fun</au><au>Kensil, Charlotte R.</au><au>Whitaker-Dowling, Patricia</au><au>Trichel, Anita</au><au>Youngner, Julius S.</au><au>Payne, Lendon G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidermal powder immunization of mice and monkeys with an influenza vaccine</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2003-06-20</date><risdate>2003</risdate><volume>21</volume><issue>21</issue><spage>2830</spage><epage>2836</epage><pages>2830-2836</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12798624</pmid><doi>10.1016/S0264-410X(03)00175-0</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2003-06, Vol.21 (21), p.2830-2836 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_18780160 |
source | Elsevier |
subjects | Adjuvant Adjuvants, Immunologic - administration & dosage Administration, Cutaneous Animals Antibodies, Viral - blood Biological and medical sciences Cholera Cholera Toxin - immunology Enzyme-Linked Immunosorbent Assay Female Fundamental and applied biological sciences. Psychology Hemagglutination Inhibition Tests Immune system Immunity, Mucosal Immunization Immunogenicity Influenza Influenza Vaccines - administration & dosage Influenza Vaccines - immunology Injection Injections, Intramuscular Macaca mulatta Methods Mice Mice, Inbred BALB C Microbiology Monkeys & apes Mortality Mucosal antibody Orthomyxoviridae Infections - immunology Orthomyxoviridae Infections - prevention & control Powders Primate Rodents Saponins - administration & dosage Saponins - immunology Species Specificity Toxins Vaccination - methods Vaccine Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Virology Viruses Waterborne diseases |
title | Epidermal powder immunization of mice and monkeys with an influenza vaccine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A33%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidermal%20powder%20immunization%20of%20mice%20and%20monkeys%20with%20an%20influenza%20vaccine&rft.jtitle=Vaccine&rft.au=Chen,%20Dexiang&rft.date=2003-06-20&rft.volume=21&rft.issue=21&rft.spage=2830&rft.epage=2836&rft.pages=2830-2836&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/S0264-410X(03)00175-0&rft_dat=%3Cproquest_cross%3E18780160%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1496648981&rft_id=info:pmid/12798624&rfr_iscdi=true |